Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shelly E Tannenbaum"'
Autor:
Shelly E Tannenbaum, Orna Singer, Yaniv Gil, Yael Berman-Zaken, Nili Ilouz, Hanita Khaner, Miriam Haimov, Benjamin E Reubinoff
Publikováno v:
Stem Cell Research, Vol 42, Iss , Pp - (2020)
The Hadassah hESC Research Center's aim is to be a supplier of clinical and research-grade human embryonic stem cell (hESC) lines. In 2012, we derived the first three entirely GMP-compliant and xeno-free, fully-characterised, feeder-dependent (human
Externí odkaz:
https://doaj.org/article/7184e255345d42c3a30d1fed56a27759
Autor:
Shelly E Tannenbaum, Tikva Tako Turetsky, Orna Singer, Einat Aizenman, Sophie Kirshberg, Nili Ilouz, Yaniv Gil, Yael Berman-Zaken, Temima Schnitzer Perlman, Nitshia Geva, Ora Levy, Daniel Arbell, Alex Simon, Assaf Ben-Meir, Yoel Shufaro, Neri Laufer, Benjamin E Reubinoff
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e35325 (2012)
Clinically compliant human embryonic stem cells (hESCs) should be developed in adherence to ethical standards, without risk of contamination by adventitious agents. Here we developed for the first time animal-component free and good manufacturing pra
Externí odkaz:
https://doaj.org/article/d8c1b5618fee468584f5e8577cfa9b2b
Publikováno v:
Cell Proliferation. 55
For use in regenerative medicine, large-scale manufacturing of human pluripotent stem cells (hPSCs) under current good manufacturing practice (cGMPs) is required. Much progress has been made since culturing under static two-dimensional (2D) condition
Autor:
Yael Berman-Zaken, Nili Ilouz, Yaniv Gil, Hanita Khaner, Shelly E. Tannenbaum, Orna Singer, Miriam Haimov, Benjamin Reubinoff
Publikováno v:
Stem Cell Research, Vol 42, Iss, Pp-(2020)
The Hadassah hESC Research Center's aim is to be a supplier of clinical and research-grade human embryonic stem cell (hESC) lines. In 2012, we derived the first three entirely GMP-compliant and xeno-free, fully-characterised, feeder-dependent (human
Autor:
S. Talib, Oliver Brüstle, L. Leopoldo, Mahendra Rao, Derek J. Hei, Miho Furue, Fanyi Zeng, Hirofumi Suemori, R. Ruttachuk, C. Hunt, N. Benvinisty, Benjamin Reubinoff, S. M. Hwang, Martin F. Pera, P.A. De Sousa, Shelly E. Tannenbaum, Outi Hovatta, Peter W. Andrews, Glyn Stacey, Meri T. Firpo, E. Han, M. C. Kibbey, Y. Nakamura, Marc Peschanski, Geoffrey P. Lomax, Douglas Sipp, L. Healy, Christine L. Mummery, Norio Nakatsuji, B. Miranda, V. Jekerle, Patricia Pranke, M. Choi, Karen Dyer Montgomery, Paul J. Gokhale, K. Bruce, Kristiina Rajala, Timo Otonkoski, Andras Nagy, Jeanne F. Loring, Qi Zhou, Sun Kyung Oh, Jeremy M. Crook, Petr Dvorak, Steve Oh, Ivana Knezevic, Christian Freund, S. K. Koo, Heather M. Rooke, B. Z. Yuan, L. Ricco, Marisa Jaconi, H. Y. Ha, David Baker, Tsuneo Takahashi, Y. Laabi, Y. M. Choi, Pentao Liu, P. Kamthorn, Tenneille Ludwig, Maneesha S. Inamdar, Simone Haupt, B. B. Knowles, K. Takada, Rosario Isasi
Publikováno v:
Regenerative medicine 10(2s), 1-44 (2015). doi:10.2217/rme.14.93
Regenerative Medicine, 10(2), 1-44
Regenerative Medicine, Vol. 10, No 2 Suppl (2015) pp. 1-44
Regenerative Medicine
Regenerative Medicine, 10(2), 1-44
Regenerative Medicine, Vol. 10, No 2 Suppl (2015) pp. 1-44
Regenerative Medicine
In 2009 the International Stem Cell Banking Initiative (ISCBI) contributors and the Ethics Working Party of the International Stem Cell Forum published a consensus on principles of best practice for the procurement, cell banking, testing and distribu
Autor:
Nili Ilouz, Ora Levy, Nitshia Geva, Tikva Turetsky, Yoel Shufaro, Yaniv Gil, Shelly E. Tannenbaum, Orna Singer, Einat Aizenman, Neri Laufer, Temima Schnitzer Perlman, Yael Berman-Zaken, Alex Simon, Benjamin Reubinoff, Daniel Arbell, Assaf Ben-Meir, Sophie Kirshberg
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e35325 (2012)
PLoS ONE
PLoS ONE
Clinically compliant human embryonic stem cells (hESCs) should be developed in adherence to ethical standards, without risk of contamination by adventitious agents. Here we developed for the first time animal-component free and good manufacturing pra